Merck sues federal government over plan to negotiate Medicare drug prices
Headline from WWL New Orleans
The plan marks the first time the federal government will bargain directly with drug companies over the price they charge for some of Medicare's costliest drugs.
WWL New Orleans's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion. The drugmaker is seeking to halt the program,
The plan marks the first time the federal government will bargain directly with drug companies over the price they charge for some of Medicare's costliest drugs.
By Katie Lobosco, CNN Washington (CNN) — The pharmaceutical company Merck sued the US government Tuesday over a law passed last year that empowers Medicare to negotiate prices of certain medications. Merck claims that the provision, included in the Inflation Reduction Act, is unconstitutional and th…
The plan marks the first time the federal government will bargain directly with drug companies over the price they charge for some of Medicare's costliest drugs.
Pharmaceutical company Merck has filed a lawsuit against the Biden administration for a new drug pricing program it says is an unconstitutional "sham."
Americans pay more for prescription medicines than any other country, and The Biden administration’s drug pricing reform aims to save $25B annually by 2031.
Merck’s lawsuit, filed in federal court in Washington, is the drug industry’s most significant move so far to fight back against a substantial change to health policy, which will go into effect starting in 2026.
Merck filed a lawsuit Tuesday challenging a new White House-backed program to limit drug prices, calling the initiative an unconstitutional "extortion" that will harm pharmaceutical innovation.
In a scathing complaint filed in federal district court, Merck excoriated the Medicare price negotiation process as a “sham” and “tantamount to extortion.”
Drugmaker Merck & Co. filed a lawsuit Tuesday alleging President Biden’s marquee effort to negotiate down the cost of drugs under Medicare is “tantamount to extortion” and violates the Constitution.
Merck (MRK), the New Jersey-based maker of widely-used cancer treatment Keytruda, filed a lawsuit Tuesday in a federal court in Washington seeking to block the drug negotiation program, created by the Inflation Reduction Act of 2022, from going into effect in 2026.
